Entera

Entera company information, Employees & Contact Information

Explore related pages

Related company profiles:

Entera is the leading 3-sided marketplace focused on connecting Enterprise and Mid-Market investors, sellers and services providers in the single-family residential market. Powered by modern data science and Artificial Intelligence (AI), Entera’s marketplace offers the most seamless solution for investors to access, evaluate, transact and operate their single-family real estate investments. Backed by leading venture capital investors Goldman Sachs Growth, Bullpen Capital, and Craft Ventures, Entera is focused on delivering software innovation and offline service solutions that enable its’ investor clients to scale their operations quickly, make more market data-driven decisions confidently, and maximize financial returns. Since its inception in 2018, Entera has transacted on more than 15,000 single family homes valued at $5 Billion across 29 US markets. The company is headquartered in New York City, New York and Houston, Texas. Learn more at www.entera.ai.

Company Details

Employees
102
Founded
-
Address
New York, New York, Us
Phone
(800) 876 - 5965
Email
in****@****tera.ai
Industry
Real Estate
Website
entera.ai
HQ
New York, New York
Looking for a particular Entera employee's phone or email?

Entera Questions

News

Entera Bio Reports Positive Phase 2 Results for Oral Anabolic Treatment EB613 at NAMS 2025, Paving Way for Global Phase 3 Study - Quiver Quantitative

Entera Bio Reports Positive Phase 2 Results for Oral Anabolic Treatment EB613 at NAMS 2025, Paving Way for Global Phase 3 Study Quiver Quantitative

AI in Real Estate: 16 Game-Changing Applications - appinventiv.com

AI in Real Estate: 16 Game-Changing Applications appinventiv.com

Generative AI Unleashes a New Era of Innovation in Commercial Real Estate - FinancialContent

Generative AI Unleashes a New Era of Innovation in Commercial Real Estate FinancialContent

Is Entera Bio Ltd. stock undervalued vs historical averages - Quarterly Portfolio Report & AI Forecast Swing Trade Picks - Trung tâm Dự báo KTTV quốc gia

Is Entera Bio Ltd. stock undervalued vs historical averages - Quarterly Portfolio Report & AI Forecast Swing Trade Picks Trung tâm Dự báo KTTV quốc gia

Entera Bio Unveils Promising PK Data for First Oral GLP-2 Therapy - Yahoo Finance

Entera Bio Unveils Promising PK Data for First Oral GLP-2 Therapy Yahoo Finance

Individual investors among Entera Bio Ltd.'s (NASDAQ:ENTX) largest shareholders, saw gain in holdings value after stock jumped 39% last week - simplywall.st

Individual investors among Entera Bio Ltd.'s (NASDAQ:ENTX) largest shareholders, saw gain in holdings value after stock jumped 39% last week simplywall.st

Entera Bio stock rating reiterated at Buy by H.C. Wainwright - Investing.com

Entera Bio stock rating reiterated at Buy by H.C. Wainwright Investing.com

Entera Bio Announces Second Quarter 2025 Financial Results and Business Updates - GlobeNewswire

Entera Bio Announces Second Quarter 2025 Financial Results and Business Updates GlobeNewswire

OPKO and Entera partner to develop obesity pill - Reuters

OPKO and Entera partner to develop obesity pill Reuters

Entera Bio Ltd. to Present Phase 2 Clinical Data for EB613 at NAMS 2025 Annual Meeting - Quiver Quantitative

Entera Bio Ltd. to Present Phase 2 Clinical Data for EB613 at NAMS 2025 Annual Meeting Quiver Quantitative

Meme Stocks: What insider purchases suggest about Entera Bio Ltd. (5DT) stock - Weekly Trading Summary & AI Forecasted Stock Moves - Trung tâm Dự báo KTTV quốc gia

Meme Stocks: What insider purchases suggest about Entera Bio Ltd. (5DT) stock - Weekly Trading Summary & AI Forecasted Stock Moves Trung tâm Dự báo KTTV quốc gia

AI in Real Estate: Use Cases, Examples, and Future Trends - Nasscom

AI in Real Estate: Use Cases, Examples, and Future Trends Nasscom

Entera Bio Advances EB613 with FDA Approval - TipRanks

Entera Bio Advances EB613 with FDA Approval TipRanks

Entera Bio to Unveil Clinical and Non-Clinical Data Across 3 Oral Peptide Programs at Upcoming September Conferences - Yahoo Finance

Entera Bio to Unveil Clinical and Non-Clinical Data Across 3 Oral Peptide Programs at Upcoming September Conferences Yahoo Finance

Here's Why We're Not Too Worried About Entera Bio's (NASDAQ:ENTX) Cash Burn Situation - simplywall.st

Here's Why We're Not Too Worried About Entera Bio's (NASDAQ:ENTX) Cash Burn Situation simplywall.st

Income Plays: Will Entera Bio Ltd. stock benefit from sector rotation - 2025 Growth vs Value & AI Enhanced Trade Execution Alerts - Trung tâm Dự báo KTTV quốc gia

Income Plays: Will Entera Bio Ltd. stock benefit from sector rotation - 2025 Growth vs Value & AI Enhanced Trade Execution Alerts Trung tâm Dự báo KTTV quốc gia

Market Brief: After Viking Therapeutics’ Results, Is Entera Bio the Oral Platform Play to Watch? (NASDAQ: ENTX) - FinancialContent

Market Brief: After Viking Therapeutics’ Results, Is Entera Bio the Oral Platform Play to Watch? (NASDAQ: ENTX) FinancialContent

Entera Bio Ltd. Stock (ENTX) Opinions on FDA Agreement for EB613 Endpoint - Quiver Quantitative

Entera Bio Ltd. Stock (ENTX) Opinions on FDA Agreement for EB613 Endpoint Quiver Quantitative

US Market Wrap: How Entera Bio Ltd. stock reacts to bond yields - 2025 Breakouts & Breakdowns & Fast Moving Market Watchlists - Trung tâm Dự báo KTTV quốc gia

US Market Wrap: How Entera Bio Ltd. stock reacts to bond yields - 2025 Breakouts & Breakdowns & Fast Moving Market Watchlists Trung tâm Dự báo KTTV quốc gia

Houston's Top 10 Startups That Tech Professionals Should Watch Out For in 2025 - nucamp.co

Houston's Top 10 Startups That Tech Professionals Should Watch Out For in 2025 nucamp.co

Entera Global Redefines Bank Statement Processing to Tally in its AI-Driven Software - PR Newswire

Entera Global Redefines Bank Statement Processing to Tally in its AI-Driven Software PR Newswire

Entera Announces $32 Million in Series A - The SaaS News

Entera Announces $32 Million in Series A The SaaS News

Entera’s oral osteoporosis drug meets endpoints in Phase II trial - Clinical Trials Arena

Entera’s oral osteoporosis drug meets endpoints in Phase II trial Clinical Trials Arena

Entera Appoints Dozie Okeleke as SVP - citybiz

Entera Appoints Dozie Okeleke as SVP citybiz

Opko, Entera share ownership of first oral GLP-1/glucagon agonist set to enter clinic - Fierce Biotech

Opko, Entera share ownership of first oral GLP-1/glucagon agonist set to enter clinic Fierce Biotech

Entera Bio Reports Positive PK Data for First-in-Class Oral GLP-2 Tablet Treatment for Patients with Short Bowel Syndrome at the 2025 ESPEN Congress - Yahoo Finance

Entera Bio Reports Positive PK Data for First-in-Class Oral GLP-2 Tablet Treatment for Patients with Short Bowel Syndrome at the 2025 ESPEN Congress Yahoo Finance

OPKO and Entera Link Up to Advance First Oral GLP-1/Glucagon Drug Into Clinic - BioSpace

OPKO and Entera Link Up to Advance First Oral GLP-1/Glucagon Drug Into Clinic BioSpace

Entera Bio Receives FDA Agreement on BMD as Primary - GlobeNewswire

Entera Bio Receives FDA Agreement on BMD as Primary GlobeNewswire

The 21 Most Promising Proptech Startups of 2022, According to VCs - businessinsider.com

The 21 Most Promising Proptech Startups of 2022, According to VCs businessinsider.com

Entera Bio reports positive data for oral osteoporosis treatment - Investing.com

Entera Bio reports positive data for oral osteoporosis treatment Investing.com

Entera Bio stock surges after FDA agrees on BMD endpoint for EB613 - Investing.com

Entera Bio stock surges after FDA agrees on BMD endpoint for EB613 Investing.com

Webinar: Mitigating thermal runaway risk in EVs with ENTERA® aerogel - Charged EVs

Webinar: Mitigating thermal runaway risk in EVs with ENTERA® aerogel Charged EVs

What risks investors should watch in Entera Bio Ltd. stock - Portfolio Return Summary & High Conviction Buy Zone Alerts - Trung tâm Dự báo KTTV quốc gia

What risks investors should watch in Entera Bio Ltd. stock - Portfolio Return Summary & High Conviction Buy Zone Alerts Trung tâm Dự báo KTTV quốc gia

Entera Bio Announces Robust Pharmacokinetic Data for First-in-Class Oral GLP-2 Peptide Tablet Treatment for Patients with Short Bowel Syndrome - Yahoo Finance

Entera Bio Announces Robust Pharmacokinetic Data for First-in-Class Oral GLP-2 Peptide Tablet Treatment for Patients with Short Bowel Syndrome Yahoo Finance

Amgen, Entera ax $270M oral biologic pact 'out of mutual convenience' - Fierce Biotech

Amgen, Entera ax $270M oral biologic pact 'out of mutual convenience' Fierce Biotech

Entera Bio stock rises after positive Phase 2 bone density data - Investing.com Nigeria

Entera Bio stock rises after positive Phase 2 bone density data Investing.com Nigeria

FDA Agrees to BMD Endpoint for First Oral Osteoporosis Drug Phase 3 Trial | ENTX Stock News - Stock Titan

FDA Agrees to BMD Endpoint for First Oral Osteoporosis Drug Phase 3 Trial | ENTX Stock News Stock Titan

The risks and rewards of AI in the housing system - PositiveMoney

The risks and rewards of AI in the housing system PositiveMoney

AI in Real Estate: 20 Companies Defining the Industry - Built In

AI in Real Estate: 20 Companies Defining the Industry Built In

Cabot ENTERATM Aerogel: Mitigating Thermal Runaway Risk in Battery Electric Vehicles - Batteries News

Cabot ENTERATM Aerogel: Mitigating Thermal Runaway Risk in Battery Electric Vehicles Batteries News

Amgen teams with Entera to develop oral biologics - Fierce Biotech

Amgen teams with Entera to develop oral biologics Fierce Biotech

ViOL Strengthens Presence in Brazil with Sylfirm X in Collaboration with ENTERA - Medical Aesthetic News

ViOL Strengthens Presence in Brazil with Sylfirm X in Collaboration with ENTERA Medical Aesthetic News

C.Tangana releases ‘Comerte Entera’ featuring Toquinho - Entertainment Focus

C.Tangana releases ‘Comerte Entera’ featuring Toquinho Entertainment Focus

26 Examples of AI in Finance 2025 - Built In

26 Examples of AI in Finance 2025 Built In

Entera Bio Reports Positive Results from a Phase 2 PK/PD - GlobeNewswire

Entera Bio Reports Positive Results from a Phase 2 PK/PD GlobeNewswire

Entera Bio (ENTX) - Zacks Investment Research

Entera Bio (ENTX) Zacks Investment Research

Critical Analysis: Precigen (NASDAQ:PGEN) and Entera Bio (NASDAQ:ENTX) - Defense World

Critical Analysis: Precigen (NASDAQ:PGEN) and Entera Bio (NASDAQ:ENTX) Defense World

Top Entera Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant